Clinical Trial Update: Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM) [Phase 2]

View source ↗

Summary

An ongoing Phase 2 clinical trial (A-DREAM) is evaluating whether interrupting hormonal therapy in exceptional responders with metastatic prostate cancer is fea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-sensitive Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING